Biggest changeThe following summarizes the persistency of our major blocks of insurance business summarized by line of business: Years ended December 31, 2022 2021 2020 Annuity: Fixed indexed annuities (1) 83.9 % 84.8 % 85.1 % Fixed interest annuities (1) 90.9 % 90.9 % 91.5 % Other annuities (2) 95.7 % 96.8 % 94.1 % Health: Supplemental health (3) 88.2 % 88.8 % 88.7 % Medicare supplement (3) 82.1 % 82.6 % 83.4 % Long-term care (3) 91.0 % 87.7 % 91.5 % Life: Traditional life (3) 84.0 % 84.8 % 85.7 % Interest-sensitive life (3) 88.8 % 88.7 % 88.7 % _____________________ (1) Based on the total amount of death benefits, surrenders values and partial withdrawals divided by the average account value.
Biggest changeIn addition, the impact of actual adjustments would reflect the net effect of all changes in assumptions during the period. 55 Table of Contents Change in assumptions Estimated adjustment to income before income taxes based on revisions to certain assumptions (dollars in millions) Annuities Fixed indexed and fixed interest annuity products: 5% increase to assumed mortality $ 3 5% decrease to assumed mortality (4) 10% increase to assumed surrender rate (3) 10% decrease to assumed surrender rate 2 50 basis point increase in interest rates (a) 68 50 basis point decrease in interest rates (a) (75) Other annuities: 5% increase to assumed mortality 5 5% decrease to assumed mortality (5) Health Medicare supplement: 5% increase to assumed mortality 2 5% decrease to assumed mortality (2) 10% increase to assumed lapse rate 3 10% decrease to assumed lapse rate (3) 10% increase to assumed morbidity (49) 10% decrease to assumed morbidity 48 Supplemental health: 5% increase to assumed mortality 8 5% decrease to assumed mortality (9) 10% increase to assumed lapse rate 20 10% decrease to assumed lapse rate (20) 10% increase to assumed morbidity (21) 10% decrease to assumed morbidity 21 Long-term care: 5% increase to assumed mortality 32 5% decrease to assumed mortality (34) 10% increase to assumed lapse rate 20 10% decrease to assumed lapse rate (20) 10% increase to assumed morbidity (75) 10% decrease to assumed morbidity 68 Life Traditional life: 5% increase to assumed mortality (34) 5% decrease to assumed mortality 35 10% increase to assumed lapse rate 6 10% decrease to assumed lapse rate (6) Interest-sensitive life products: 5% increase to assumed mortality (6) 5% decrease to assumed mortality 6 10% increase to assumed lapse rate 1 10% decrease to assumed lapse rate (1) _____________________ (a) The estimated impact of the hypothetical 50 basis point increase or decrease in interest rates related to our fixed indexed and fixed interest annuity products would be reflected in our pre-tax non-operating earnings. 56 Table of Contents The following summarizes the persistency of our major blocks of insurance business summarized by line of business: Years ended December 31, 2023 2022 2021 Annuity: Fixed indexed annuities (1) 89.7 % 90.9 % 90.9 % Fixed interest annuities (1) 83.4 % 83.9 % 84.8 % Other annuities (2) 97.2 % 95.7 % 96.8 % Health: Supplemental health (3) 88.5 % 88.2 % 88.8 % Medicare supplement (3) 84.3 % 82.1 % 82.6 % Long-term care (3) 90.5 % 91.0 % 87.7 % Life: Traditional life (3) 83.9 % 84.0 % 84.8 % Interest-sensitive life (3) 89.1 % 88.8 % 88.7 % _____________________ (1) Based on the total amount of death benefits, surrenders values and partial withdrawals divided by the average account value.
Income from insurance products is the sum of the insurance margins of the annuity, health and life product lines, less expenses allocated to the insurance lines. It excludes the income from our fee income business, investment income not allocated to product lines, net expenses not allocated to product lines (primarily holding company expenses) and income taxes.
Income from insurance products is the sum of the insurance margins of the annuity, health and life product lines, less expenses allocated to the insurance lines. It excludes the income from our fee income business, investment income not allocated to product lines, net expenses not allocated to product lines (primarily holding company expenses) and income taxes.
Ratings have the most impact on our Worksite sales of supplemental health and life products since such ratings are often an important factor considered by employers. The current financial strength ratings of our primary insurance subsidiaries from AM Best, Fitch, Moody's and S&P are "A", "A-", "A3" and "A-", respectively.
Ratings have the most impact on our Worksite sales of supplemental health and life products since such ratings are often an important factor considered by employers. The current financial strength ratings of our primary insurance subsidiaries from Fitch, S&P, Moody's and AM Best are "A", "A-", "A3" and "A", respectively.
We are subject to the risk that our investments will decline in value if interest rates continue to rise. The Company is subject to risk resulting from fluctuations in market prices of our equity securities. In general, these investments have more year-to-year price variability than our fixed maturity investments. However, returns over longer time frames have been consistently higher.
We are subject to the risk that our investments will decline in value if interest rates rise. The Company is subject to risk resulting from fluctuations in market prices of our equity securities. In general, these investments have more year-to-year price variability than our fixed maturity investments. However, returns over longer time frames have been consistently higher.
Investment income not allocated to product lines includes investment income on investments in excess of amounts allocated to product lines, investments held by our holding companies, the spread we earn from our FHLB investment borrowing and FABN programs and variable components of investment income (including call and prepayment income, adjustments to returns on structured securities due to cash flow changes, income (loss) from Company-owned life insurance ("COLI") and alternative investment income not allocated to product lines), net of interest expense on corporate debt.
Investment income not allocated to product lines includes investment income on investments in excess of amounts allocated to product lines, investments held by our holding companies, the spread we earn from our FHLB investment borrowing and FABN programs and variable components of investment income (including call and prepayment income, adjustments to returns on structured securities due to cash flow changes, income (loss) from Company-owned life insurance ("COLI") and alternative investment income not allocated to product lines), net of interest expense on corporate debt and financing arrangements.
Investment income not allocated to product lines includes investment income on investments in excess of amounts allocated to product lines, investments held by our holding companies, the spread we earn from our FHLB investment borrowing and FABN programs and variable components of investment income (including call and prepayment income, adjustments to returns on structured securities due to cash flow changes, income (loss) from COLI and alternative investment income not allocated to product lines), net of interest expense on corporate debt.
Investment income not allocated to product lines includes investment income on investments in excess of amounts allocated to product lines, investments held by our holding companies, the spread we earn from our FHLB investment borrowing and FABN programs and variable components of investment income (including call and prepayment income, adjustments to returns on structured securities due to cash flow changes, income (loss) from COLI and alternative investment income not allocated to product lines), net of interest expense on corporate debt and financing arrangements.
Our RBC ratio at December 31, 2022, exceeded our targeted statutory RBC ratio of 375 percent and the minimum 350 percent that is reflected in our risk appetite statement that we share and discuss with rating agencies and insurance regulators. We believe that the 375 percent RBC ratio target continues to adequately support our financial strength and credit ratings.
Our RBC ratio at December 31, 2023, exceeded our targeted statutory RBC ratio of 375 percent and the minimum 350 percent that is reflected in our risk appetite statement that we share and discuss with rating agencies and insurance regulators. We believe that the 375 percent RBC ratio target continues to adequately support our financial strength and credit ratings.
(b) Includes projected interest payments based on interest rates, as applicable, as of December 31, 2022. Refer to the note to the consolidated financial statements entitled "Notes Payable - Direct Corporate Obligations" for additional information on notes payable. (c) These borrowings represent collateralized borrowings from the FHLB and projected interest payments on such borrowings.
(b) Includes projected interest payments based on interest rates, as applicable, as of December 31, 2023. Refer to the note to the consolidated financial statements entitled "Notes Payable - Direct Corporate Obligations" for additional information on notes payable. (c) These borrowings represent collateralized borrowings from the FHLB and projected interest payments on such borrowings.
Risk Factors - A prolonged low interest rate environment may negatively impact our results of operations, financial position and cash flows" for additional information on interest rate risks. We simulate the cash flows expected from our existing insurance business under various interest rate scenarios.
Risk Factors - A return to a prolonged low interest rate environment may negatively impact our results of operations, financial position and cash flows" for additional information on interest rate risks. We simulate the cash flows expected from our existing insurance business under various interest rate scenarios.
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF CONSOLIDATED FINANCIAL CONDITION AND RESULTS OF OPERATIONS. In this section, we review the consolidated financial condition of CNO and its consolidated results of operations for the years ended December 31, 2022, 2021 and 2020 and, where appropriate, factors that may affect future financial performance.
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF CONSOLIDATED FINANCIAL CONDITION AND RESULTS OF OPERATIONS. In this section, we review the consolidated financial condition of CNO and its consolidated results of operations for the years ended December 31, 2023, 2022 and 2021 and, where appropriate, factors that may affect future financial performance.
CRITICAL ACCOUNTING ESTIMATES The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of various assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reporting period.
CRITICAL ACCOUNTING ESTIMATES The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of various assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements as well as revenues and expenses during the reporting period.
There are six ratings above the "A-" rating of our primary insurance subsidiaries and fourteen ratings that are below that rating. Rating agencies have increased the frequency and scope of their credit reviews and requested additional information from the companies that they rate, including us.
There are six ratings above the "A3" rating of our primary insurance subsidiaries and fourteen ratings that are below that rating. Rating agencies have increased the frequency and scope of their credit reviews and requested additional information from the companies that they rate, including us.
Our estimates of future taxable income are based on evidence we consider to be objectively verifiable. At December 31, 2022, our projection of future taxable income for purposes of determining the valuation allowance is based on our estimates of such future taxable income through the date our NOLs expire.
Our estimates of future taxable income are based on evidence we consider to be objectively verifiable. At December 31, 2023, our projection of future taxable income for purposes of determining the valuation allowance is based on our estimates of such future taxable income through the date our NOLs expire.
In AM Best's view, a company rated "bbb" has an adequate ability to meet the terms of its obligations; however, the issuer is more susceptible to changes in economic or other conditions. Pluses and minuses show the relative standing within a category. AM Best has a total of 22 possible ratings ranging from "aaa (Exceptional)" to "d (In default)".
In AM Best's view, a company rated "bbb" has an adequate ability to meet the terms of its obligations; however, the issuer is more susceptible to changes in economic or other conditions. Pluses and minuses show the relative standing within a category. AM Best has a total of twenty-two possible ratings ranging from "aaa (Exceptional)" to "d (In default)".
Many of our products include surrender charges, market interest rate adjustments or other features to encourage persistency; however, at December 31, 2022, approximately $4.5 billion of our total insurance liabilities could be surrendered by the policyholder without penalty. Finally, changes in interest rates can have significant effects on our investment portfolio.
Many of our products include surrender charges, market interest rate adjustments or other features to encourage persistency; however, at December 31, 2023, approximately $4.4 billion of our total insurance liabilities could be surrendered by the policyholder without penalty. Finally, changes in interest rates can have significant effects on our investment portfolio.
We have assumed that revisions to assumptions resulting in such adjustments would occur equally among policy types, ages and durations within each product classification. Any actual adjustment would be dependent on the specific policies affected and, therefore, may differ from such estimates.
We have assumed that revisions to assumptions resulting in the adjustments summarized below would occur equally among policy types, ages and durations within each product classification. Any actual adjustment would be dependent on the specific policies affected and, therefore, may differ from the estimates summarized below.
We estimated these payments based on our historical experience and our expectation of future payment patterns which is consistent with the assumptions used in our loss recognition testing for these blocks of business. • The average interest rate we assumed would be credited to our total insurance liabilities (excluding interest rate bonuses for the first policy year only and excluding the effect of credited rates attributable to variable or fixed indexed products) over the term of the contracts was 4.4 percent.
We estimated these payments based on our historical experience and our expectation of future payment patterns which is consistent with the assumptions used in our reserve calculations for these blocks of business. • The average interest rate we assumed would be credited to our total insurance liabilities (excluding interest rate bonuses for the first policy year only and excluding the effect of credited rates attributable to variable or fixed indexed products) over the term of the contracts was 4.4 percent.
If we intend to sell an impaired fixed maturity security, available for sale, or identify an impaired fixed maturity security, available for sale, for which is it more likely than not we will be required to sell before anticipated recovery, the difference between the fair value and the amortized cost is included in net investment gains (losses) and the fair value becomes the new amortized cost.
If we intend to sell an impaired fixed maturity security, available for sale, or identify an impaired fixed maturity security, available for sale, for which is it more likely than not we will be required to sell before anticipated recovery, the 52 Table of Contents difference between the fair value and the amortized cost is included in net investment gains (losses) and the fair value becomes the new amortized cost.
The ratio is determined after three years from the original issuance of the policy and over the lifetime of the policy and measured in accordance with statutory accounting principles.
The ratio is determined after three years from the original issuance of the policy and over the lifetime of the policy and measured in accordance with U.S. statutory accounting principles.
Free cash flow is a measure of holding company liquidity and is calculated as: (i) dividends, management fees and surplus debenture interest payments received from our subsidiaries; plus (ii) earnings on corporate investments; less (iii) interest expense, corporate expenses and net tax payments. In 2022, we generated $178 million of such free cash flow.
Free cash flow is a measure of holding company liquidity and is calculated as: (i) dividends, management fees and surplus debenture interest payments received from our subsidiaries; plus (ii) earnings on corporate investments; less (iii) interest expense, corporate expenses and net tax payments. In 2023, we generated $311 million of such free cash flow.
The new cost basis is not adjusted for any subsequent recoveries in fair value. 52 Table of Contents Future events may occur, or additional information may become available, which may necessitate future realized losses in our portfolio. Significant losses could have a material adverse effect on our consolidated financial statements in future periods.
The new cost basis is not adjusted for any subsequent recoveries in fair value. Future events may occur, or additional information may become available, which may necessitate future realized losses in our portfolio. Significant losses could have a material adverse effect on our consolidated financial statements in future periods.
Please read this discussion in conjunction with the consolidated financial statements and notes included in this Form 10-K. OVERVIEW We are a holding company for a group of insurance companies operating throughout the United States that develop, market and administer health insurance, annuity, individual life insurance and other insurance and financial services products.
Please read this discussion in conjunction with the consolidated financial statements and notes included in this Form 10-K. OVERVIEW We are a holding company for a group of insurance companies that develop, market and administer health insurance, annuity, individual life insurance and other insurance and financial services products.
During 2022, 2021 and 2020, we recognized an increase (decrease) in earnings of $48.9 million, $8.9 million and $(16.3) million, respectively, for the mark-to-market change in the agent deferred compensation plan liability which was impacted by changes in the underlying actuarial assumptions used to value the liability.
During 2023, 2022 and 2021, we recognized an increase (decrease) in earnings of $(3.5) million, $48.9 million and $8.9 million, respectively, for the mark-to-market change in the agent deferred compensation plan liability which was impacted by changes in the underlying actuarial assumptions used to value the liability.
On February 1, 2023, AM Best affirmed its "A" financial strength ratings of our primary insurance subsidiaries and the outlook for these ratings is stable. The "A" rating is assigned to companies that have an excellent ability, in AM Best's opinion, to meet their ongoing obligations to policyholders.
On February 15, 2024, AM Best affirmed its "A" financial strength ratings of our primary insurance subsidiaries and the outlook for these ratings is stable. The "A" rating is assigned to companies that have an excellent ability, in AM Best's opinion, to meet their ongoing obligations to policyholders.
Recovery of our deferred tax asset is dependent on achieving the level of future taxable income projected in our deferred tax valuation model and failure to do so could result in an increase in the valuation allowance in a future period.
Recovery of our deferred tax asset is dependent on achieving the level of future taxable income projected in our deferred tax valuation model and failure to do so could result in the recognition of a valuation allowance in a future period.
In October 2021, Bankers Life issued a funding agreement to a series of the Trust in an aggregate principal amount of $500 million. In January 2022, Bankers Life issued two additional funding agreements, each to a series of the Trust, totaling $900 million.
In October 2021, Bankers Life issued a funding agreement to a series of the Trust in an aggregate principal amount of $500 million. In January 2022, Bankers Life issued two additional funding agreements, each to a series of 79 Table of Contents the Trust, totaling $900 million.
As a result, total outflows for all years exceed the corresponding liabilities of $27.4 billion included in our consolidated balance sheet as of December 31, 2022. As such payments are based on numerous assumptions, the actual payments may vary significantly from the amounts shown.
As a result, total outflows for all years exceed the corresponding liabilities of $27.9 billion included in our consolidated balance sheet as of December 31, 2023. As such payments are based on numerous assumptions, the actual payments may vary significantly from the amounts shown.
The borrowings are collateralized by investments with an estimated fair value of $2.2 billion at December 31, 2022, which are maintained in custodial accounts for the benefit of the FHLB.
The borrowings are collateralized by investments with an estimated fair value of $2.7 billion at December 31, 2023, which are maintained in custodial accounts for the benefit of the FHLB.
The cash value rider is similar to the return of premium rider, but also provides for payment of a graded portion of the return of premium benefit if the policy terminates before the return of premium benefit is earned.
The 64 Table of Contents cash value rider is similar to the return of premium rider, but also provides for payment of a graded portion of the return of premium benefit if the policy terminates before the return of premium benefit is earned.
We estimated these payments using actuarial models based on historical experience and our expectation of the future payment patterns which is consistent with the assumptions used in our loss recognition testing for these blocks of business. • For short-term insurance products such as Medicare supplement insurance, the future payments relate only to amounts necessary to settle all outstanding claims, including those that have been incurred but not reported as of the balance sheet date.
We estimated these payments using actuarial models based on historical experience and our expectation of the future payment patterns which is consistent with the assumptions used in our reserve calculations for these blocks of business. • For insurance products such as Medicare supplement insurance, the future payments relate only to amounts necessary to settle all outstanding claims, including those that have been incurred but not reported as of the balance sheet date.
At December 31, 2022, the carrying value of the FHLB common stock was $75.2 million. As of December 31, 2022, collateralized borrowings from the FHLB totaled $1.6 billion and the proceeds were used to purchase matched variable rate fixed maturity securities. The borrowings are classified as investment borrowings in the accompanying consolidated balance sheet.
At December 31, 2023, the carrying value of the FHLB common stock was $94.6 million. As of December 31, 2023, collateralized borrowings from the FHLB totaled $2.2 billion and the proceeds were used to purchase matched variable rate fixed maturity securities. The borrowings are classified as investment borrowings in the accompanying consolidated balance sheet.
However, adverse economic conditions or changing circumstances are more likely to lead to a weakened capacity of the obligor to meet its financial commitment on the obligation. Pluses and minuses show the relative standing within a category. S&P has a total of 22 possible ratings ranging from "AAA (Extremely Strong)" to "D (Payment Default)".
However, adverse economic conditions or changing circumstances are more likely to lead to a weakened capacity of the obligor to meet its financial commitment on the obligation. Pluses and minuses show the relative standing within a category. S&P has a total of 83 Table of Contents twenty-two possible ratings ranging from "AAA (Extremely Strong)" to "D (Payment Default)".
(d) These borrowings represent the securities issued by VIEs and include projected interest payments based on interest rates, as applicable, as of December 31, 2022. 79 Table of Contents (e) Includes benefits expected to be paid pursuant to our deferred compensation plan and postretirement plans based on numerous actuarial assumptions and interest credited at 5.25 percent.
(d) These borrowings represent the securities issued by VIEs and include projected interest payments based on interest rates, as applicable, as of December 31, 2023. 78 Table of Contents (e) Includes benefits expected to be paid pursuant to our deferred compensation plan and postretirement plans based on numerous actuarial assumptions and interest credited at 5.00 percent.
In May 2022, the Company increased its quarterly common stock dividend to $0.14 per share from $0.13 per share. On February 1, 2023, AM Best affirmed its "bbb" rating on our issuer credit and senior unsecured debt and the outlook for these ratings is stable.
In May 2023, the Company increased its quarterly common stock dividend to $0.15 per share from $0.14 per share. On February 15, 2024, AM Best affirmed its "bbb" rating on our issuer credit and senior unsecured debt and the outlook for these ratings is stable.
The following table sets forth the aggregate amount of dividends (net of capital contributions) and other distributions that our insurance subsidiaries paid to our non-insurance subsidiaries in each of the last three fiscal years (dollars in millions): Years ended December 31, 2022 2021 2020 Dividends (net of contributions) from insurance subsidiaries $ 129.0 $ 328.3 $ 294.1 Surplus debenture interest 58.8 55.4 57.4 Fees for services provided pursuant to service agreements 124.0 117.8 111.7 Total dividends and other distributions paid by insurance subsidiaries $ 311.8 $ 501.5 $ 463.2 The ability of our insurance subsidiaries to pay dividends is subject to state insurance department regulations and is based on the financial statements of our insurance subsidiaries prepared in accordance with statutory accounting practices prescribed or permitted by regulatory authorities, which differ from GAAP.
The following table sets forth the aggregate amount of dividends (net of capital contributions) and other distributions that our insurance subsidiaries paid to our non-insurance subsidiaries in each of the last three fiscal years (dollars in millions): Years ended December 31, 2023 2022 2021 Dividends (net of contributions) from insurance subsidiaries $ 227.1 $ 129.0 $ 328.3 Surplus debenture interest 82.0 58.8 55.4 Fees for services provided pursuant to service agreements 116.1 124.0 117.8 Total dividends and other distributions paid by insurance subsidiaries $ 425.2 $ 311.8 $ 501.5 The ability of our U.S. based insurance subsidiaries to pay dividends is subject to state insurance department regulations and is based on the financial statements of our insurance subsidiaries prepared in accordance with statutory accounting practices prescribed or permitted by regulatory authorities, which differ from GAAP.
We have experienced a shift in the sale of Medicare supplement policies to the sale of Medicare Advantage policies. We receive fee income when Medicare Advantage policies of other providers are sold, which is recorded in our Fee income segment.
Over the last several years, we have experienced a shift in the sale of Medicare supplement policies to the sale of Medicare Advantage policies. We receive fee income when Medicare Advantage policies of other providers are sold, which is recorded in our Fee income segment.
The amount and timing of future share repurchases (if any) will be based on business and market conditions and other factors including, but not limited to, available free cash flow, the current price of our common stock and investment opportunities. In 2022, we repurchased 7.6 million shares of common stock for $180.0 million under our securities repurchase program.
The amount and timing of future share repurchases (if any) will be based on business and market conditions and other factors including, but not limited to, available free cash flow, the current price of our common stock and investment opportunities. In 2023, we repurchased 6.6 million shares of common stock for $165.1 million under our securities repurchase program.
At December 31, 2022, the weighted average yield, computed on the cost basis of investments allocated to our product lines, was approximately 4.6 percent, and the average interest rate credited or accruing to our total insurance liabilities (excluding interest rate bonuses for the first policy year only and excluding the effect of credited rates attributable to variable or fixed indexed products) was 4.4 percent.
At December 31, 2023, the weighted average yield, computed on the cost basis of investments allocated to our product lines, was approximately 4.7 percent, and the average interest rate credited or accruing to our total insurance liabilities (excluding interest rate bonuses for the first policy year only and excluding the effect of credited rates attributable to variable or 84 Table of Contents fixed indexed products) was 4.4 percent.
Also, as we adopt the new accounting standard related to targeted improvements to the accounting for long-duration insurance contracts effective January 1, 2023, we will be updating our method of determining non-operating earnings for our fixed indexed annuities to better identify the volatile non-economic impacts of that line of business.
Also, as we adopted the new accounting standard related to targeted improvements to the accounting for long-duration insurance contracts effective January 1, 2023, we updated our method of determining non-operating earnings for our fixed indexed annuities to better identify the volatile non-economic impacts of that line of business.
Total asset adequacy and premium deficiency reserves for Bankers Life, Washington National and Bankers Conseco Life Insurance Company were $50.0 million, $134.5 million and $34.5 million, respectively, at December 31, 2022.
Total asset adequacy and premium deficiency reserves for Bankers Life, Washington National and Bankers Conseco Life Insurance Company were $70.0 million, $134.5 million and $34.5 million, respectively, at December 31, 2023.
When analyzing profitability of these segments, we use insurance product margin as the measure of profitability, which is: (i) insurance policy income; and (ii) net investment income allocated to the insurance product lines; less (i) insurance policy benefits and interest credited to policyholders; and (ii) amortization, non-deferred commissions and advertising expense.
When analyzing profitability of these segments, we use insurance product margin as the measure of profitability, which is: (i) insurance policy income; and (ii) net investment income allocated to the insurance product lines; less (i) insurance policy benefits and interest credited to policyholders; and (ii) amortization of deferred acquisition costs and present value of future profits, non-deferred commissions and advertising expense.
Changes in Actuarial Assumptions: We update the assumptions and experience underlying the expected gross margins for policies accounted for as investment contracts annually in the fourth quarter of each year.
Comprehensive Annual Actuarial Review: We update the assumptions and experience underlying the expected gross margins for policies accounted for as investment contracts annually in the fourth quarter of each year.
Management has made estimates in the past that we believed to be appropriate but were subsequently revised to reflect actual experience. If our future experience differs materially from these estimates and assumptions, our results of operations and financial condition could be materially affected.
Management has made estimates in the past that we believed to be appropriate but were subsequently revised as actual experience developed differently than expected. If our future experience differs materially from these estimates and assumptions, our results of operations and financial condition could be materially affected.
During 2022, the financial statements of three of our insurance subsidiaries prepared in accordance with statutory accounting practices prescribed or permitted by regulatory authorities reflected asset adequacy or premium deficiency reserves.
During 2023, the financial statements of three of our U.S. based insurance subsidiaries prepared in accordance with statutory accounting practices prescribed or permitted by regulatory authorities reflected asset adequacy or premium deficiency reserves.
At December 31, 2022, we held investments with an amortized cost of $1,134.2 million and an estimated fair value of $1,077.6 million related to VIEs that we are required to consolidate. The investment portfolio held by the VIEs is primarily comprised of commercial bank loans, the borrowers for which are almost entirely rated below-investment grade.
At December 31, 2023, we held investments with an amortized cost of $787.6 million and an estimated fair value of $768.6 million related to VIEs that we are required to consolidate. The investment portfolio held by the VIEs is primarily comprised of commercial bank loans, the borrowers for which are almost entirely rated below-investment grade.
Our model is adjusted to reflect changes in our projections of future taxable income including changes resulting from the Tax Reform Act, investment strategies, the impact of the sale or reinsurance of business, the recapture of business previously ceded, tax planning strategies and the COVID-19 pandemic.
Our model is adjusted to reflect changes in our projections of future taxable income including changes resulting from the Tax Cuts and Job Act, investment strategies, the impact of the sale or reinsurance of business, the recapture of business previously ceded and tax planning strategies.
Consistent with this strategy, investments in fixed maturity securities and mortgage loans made up 90 percent of our $24.3 billion investment portfolio at December 31, 2022. The remainder of the invested assets was trading securities, investments held by VIEs, COLI, equity securities, policy loans and other invested assets.
Consistent with this strategy, investments in fixed maturity securities and mortgage loans made up 90 percent of our $26.1 billion investment portfolio at December 31, 2023. The remainder of the invested assets was trading securities, investments held by VIEs, equity securities, policy loans and other invested assets.
As of December 31, 2022, approximately 14 percent of our insurance liabilities had interest rates that may be reset annually; 49 percent had a fixed explicit interest rate for the duration of the contract; 34 percent are fixed indexed products where the income earned is subject to a participation rate that typically may be changed annually; and the remainder had no explicit interest rates.
As of December 31, 2023, approximately 13 percent of our insurance liabilities had interest rates that may be reset annually; 48 percent had a fixed explicit interest rate for the duration of the contract; 36 percent are fixed indexed products where the income earned is subject to a participation rate that typically may be changed annually; and the remainder had no explicit interest rates.
Interest payments on those surplus debentures do not require additional approval provided the RBC ratio of CLTX exceeds 100 percent (but do 82 Table of Contents require prior written notice to the Texas Department of Insurance). The estimated RBC ratio of CLTX was 340 percent at December 31, 2022.
Interest payments on those surplus debentures do not require additional approval provided the RBC ratio of CLTX exceeds 100 percent (but do require prior written notice to the Texas Department of Insurance). The estimated RBC ratio of CLTX was 345 percent at December 31, 2023.
Investment income not allocated to product lines generally fluctuates from period to period based on the level of prepayment income (including call premiums) and trading account income; the performance of our alternative investments (which are typically reported a quarter in arrears); the earnings related to the investments underlying our COLI; and the spread we earn from our FHLB investment borrowing and FABN programs. 62 Table of Contents Expenses not allocated to product lines includes certain significant items listed in the table below.
Investment income not allocated to product lines generally fluctuates from period to period based on the level of prepayment income (including call premiums) and trading account income; the performance of our alternative investments (which are typically reported a quarter in arrears); the earnings related to the investments underlying our COLI; and the spread we earn from our FHLB investment borrowing and FABN programs.
The interest margin was $5.2 million in 2022, compared to $6.5 million in 2021 and $3.6 million in 2020. Net investment income was higher in 2022, compared to 2021 and 2020. The increase in average net insurance liabilities results in higher net investment income allocated, which is partially offset by lower earned yields.
The interest margin was $2.8 million in 2023 compared to $3.3 million in 2022 and $5.1 million in 2021. Net investment income in 2023 was comparable to 2022 and 2021. The increase in average net insurance liabilities results in higher net investment income allocated, which is offset by lower earned yields.
The weighted average crediting rates at December 31, 2022, related to such annuity and universal life account values, that were at the minimum guaranteed crediting rate were 2.11 percent and 4.49 percent, respectively.
The weighted average crediting rates at December 31, 2023, related to such annuity and universal life account values, that were at the minimum guaranteed crediting rate were 2.21 percent and 4.0 percent, respectively.
At December 31, 2022, the estimated duration of our fixed income securities (as modified to reflect estimated prepayments and call premiums) and the estimated duration of our insurance liabilities were approximately 8.3 years and 8.4 years, respectively.
At December 31, 2023, the estimated duration of our fixed income securities (as modified to reflect estimated prepayments and call premiums) and the estimated duration of our insurance liabilities were approximately 8.1 years and 8.2 years, respectively.
Our trading securities include: (i) investments purchased with the intent of selling in the near term to generate income; and (ii) certain fixed maturity securities containing embedded derivatives for which we have elected the fair value option.
We carry trading securities at estimated fair value; changes in fair value are reflected in the statement of operations. Our trading securities include: (i) investments purchased with the intent of selling in the near term to generate income; and (ii) certain fixed maturity securities containing embedded derivatives for which we have elected the fair value option.
Investment income not allocated to product lines represents net investment income less: (i) equity returns credited to policyholder account balances; (ii) the investment income allocated to our product lines; (iii) interest expense on notes payable and investment borrowings; (iv) expenses related to the funding agreement-backed note ("FABN") program; 48 Table of Contents and (v) certain expenses related to benefit plans that are offset by special-purpose investment income.
Investment income not allocated to product lines represents net investment income less: (i) equity returns credited to policyholder account balances; (ii) the investment income allocated to our product lines; (iii) interest expense 49 Table of Contents on notes payable and investment borrowings; (iv) expenses related to the funding agreement-backed note ("FABN") program; and (v) certain expenses related to benefit plans that are offset by special-purpose investment income; plus (vi) the impact of annual option forfeitures related to fixed indexed annuity surrenders.
The Company had remaining repurchase authority of $186.9 million as of December 31, 2022. In 2022, 2021 and 2020, dividends declared on common stock totaled $65.0 million ($0.55 per common share), $66.1 million ($0.51 per common share) and $67.4 million ($0.47 per common share), respectively.
The Company had remaining repurchase authority of $521.8 million as of December 31, 2023. In 2023, 2022 and 2021, dividends declared on common stock totaled $67.9 million ($0.59 per common share), $65.0 million ($0.55 per common share) and $66.1 million ($0.51 per common share), respectively.
Our commercial mortgage loan portfolio is primarily comprised of large commercial mortgage loans. Approximately 16 percent, 10 percent, 7 percent and 7 percent of the commercial mortgage loan balance were on properties located in California, Maryland, Wisconsin and Georgia, respectively. No other state comprised greater than six percent of the mortgage loan balance.
Our commercial mortgage loan portfolio is primarily comprised of large commercial mortgage loans. Approximately 16 percent, 8 percent, 6 percent and 6 percent of the commercial mortgage loan balance were on properties located in California, Maryland, Wisconsin and Indiana, respectively. No other state comprised greater than five percent of the mortgage loan balance.
However, as each of the immediate insurance subsidiaries of CDOC has significant negative earned surplus, any dividend payments from the insurance subsidiaries require the prior approval of the director or commissioner of the applicable state insurance department. In 2022, our insurance subsidiaries paid dividends to CDOC totaling $143.6 million.
However, as each of the immediate U.S. based insurance subsidiaries of CDOC has significant negative earned surplus, any dividend payments from the insurance subsidiaries require the prior approval of the director or commissioner of the applicable state insurance department. In 2023, our U.S. based insurance subsidiaries paid dividends to CDOC totaling $526.5 million.
An insurer rated "A", in S&P's opinion, has strong financial security characteristics, but is somewhat more likely to be affected by adverse business conditions than are insurers with higher ratings. Pluses and minuses show the relative standing 81 Table of Contents within a category. S&P has twenty-one possible ratings.
S&P financial strength ratings range from "AAA" to "R" and some companies are not rated. An insurer rated "A", in S&P's opinion, has strong financial security characteristics, but is somewhat more likely to be affected by adverse business conditions than are insurers with higher ratings. Pluses and minuses show the relative standing within a category. S&P has twenty-one possible ratings.
There are nine ratings above CNO's "Baa3" rating and eleven ratings that are below its rating. S&P most recently reviewed its "BBB-" rating on our senior unsecured debt on July 15, 2022. The outlook for these ratings is stable. In S&P's view, an obligation rated "BBB" exhibits adequate protection parameters.
There are eight ratings above CNO's "BBB+" rating and twelve ratings that are below its rating. S&P most recently reviewed its "BBB-" rating on our senior unsecured debt on June 23, 2023. The outlook for these ratings is stable. In S&P's view, an obligation rated "BBB" exhibits adequate protection parameters.
Investment income not allocated to product lines represents net investment income less: (i) equity returns credited to policyholder account balances; (ii) the investment income allocated to our product lines; (iii) interest expense on notes payable and investment borrowings; (iv) expenses related to the FABN program; and (v) certain expenses related to benefit plans that are offset by special-purpose investment income.
Investment income not allocated to product lines represents net investment income less: (i) equity returns credited to policyholder account balances; (ii) the investment income allocated to our product lines; (iii) interest expense on notes payable, investment borrowings and financing arrangements; (iv) expenses related to the FABN program; and (v) certain expenses related to benefit plans that are offset by special-purpose investment income; plus (vi) the impact of annual option forfeitures related to fixed indexed annuity surrenders.
INVESTMENTS Our investment strategy is to: (i) provide largely stable investment income from a diversified high quality fixed income portfolio; (ii) mitigate the effect of changing interest rates through active asset/liability management; (iii) provide liquidity to meet our cash obligations to policyholders and others; and (iv) maximize total return through active strategic asset allocation and investment management.
INVESTMENTS Our investment strategy is to: (i) provide largely stable investment income from a diversified high quality fixed income portfolio; (ii) mitigate the effect of changing interest rates through active asset/liability management; (iii) provide liquidity to meet our cash obligations to policyholders and others; (iv) maximize total return through active strategic asset allocation and investment management, while managing the capital efficiency of the portfolio; and (v) use outside managers in specialized investment classes to add value to our overall strategy.
During 2022, we sold $1,651.5 million of fixed maturity investments which resulted in gross realized investment losses (before income taxes) of $104.0 million. Securities are generally sold at a loss following unforeseen issue-specific events or conditions or shifts in perceived relative values.
During 2023, we sold $712.2 million of fixed maturity investments which resulted in gross realized investment losses (before income taxes) of $58.9 million. Securities are generally sold at a loss following unforeseen issue-specific events or conditions or shifts in perceived relative values.
Net investment income and interest credited excludes the change in market values of the underlying options supporting the fixed indexed life products and corresponding offsetting amount credited to policyholder account balances. Such amounts were $(24.0) million, $24.3 million and $5.5 million in 2022, 2021 and 2020, respectively.
Net investment income and interest credited exclude the change in market values of the underlying options supporting the fixed indexed annuity products and corresponding offsetting amount credited to policyholder account balances. Such amounts were $118.3 million, $(181.3) million and $195.5 million in 2023, 2022 and 2021, respectively.
As the policies age, insurance policy benefits will typically increase, but the increase in benefits will be partially offset by investment income earned on the accumulated assets. Margin from Medicare supplement business was $145.8 million in 2022, compared to $164.0 million in 2021 and $188.3 million in 2020.
As the policies age, insurance policy benefits will typically increase, but the increase in benefits will be partially offset by investment income earned on the accumulated assets. Margin from Medicare supplement business was $116.9 million in 2023 compared to $151.0 million in 2022 and $162.5 million in 2021.
We recognize the mark-to-market change in the estimated value of this liability through earnings as assumptions change. During 2022, 2021 and 2020, we recognized an increase (decrease) in earnings of $247.2 million, $67.2 million and $(79.1) million, respectively, resulting from changes in the estimated fair value of embedded derivative liabilities related to our fixed indexed annuities, net of related amortization.
We recognize the mark-to-market change in the estimated value of this liability through earnings as assumptions change. During 2023, 2022 and 2021, we recognized an increase (decrease) in earnings of $(29.9) million, $440.2 million and $186.8 million, respectively, resulting from changes in the fair value of embedded derivative liabilities and MRBs related to our fixed indexed annuities.
During 2022, we recognized net investment losses of $135.4 million, which were comprised of: (i) $9.6 million of net losses from the sales of investments; (ii) $11.2 million of losses related to equity securities, including the change in fair value; (iii) the decrease in fair value of certain other invested assets and fixed maturity investments with embedded derivatives of $45.9 million; (iv) the decrease in fair value of embedded derivatives related to a modified coinsurance agreement of $16.1 million; and (v) an increase in the allowance for credit losses of $52.6 million.
During 2023, we recognized net investment losses of $69.0 million, which were comprised of: (i) $68.7 million of net losses from the sales of investments; (ii) $0.2 million of losses related to equity securities, including the change in fair value; (iii) the net decrease in fair value of certain other invested assets and fixed maturity investments with embedded derivatives of $8.5 million; (iv) the increase in fair value of embedded derivatives related to a modified coinsurance agreement of $0.3 million; and (v) a decrease in the allowance for credit losses of $8.1 million.
General account investments exclude the value of options. 2022 2021 2020 (dollars in millions) Weighted average investments at amortized cost allocated to product lines $ 19,661.2 $ 18,877.0 $ 18,093.0 Allocated investment income 900.6 894.8 887.0 Average yield on allocated investments 4.58 % 4.74 % 4.90 % Insurance statutes regulate the types of investments that our insurance subsidiaries are permitted to make and limit the amount of funds that may be used for any one type of investment.
General account investments exclude the value of options. 2023 2022 2021 (dollars in millions) Weighted average investments at amortized cost allocated to product lines $ 20,567.5 $ 19,987.5 $ 19,098.8 Allocated investment income 957.8 915.2 905.6 Average yield on allocated investments 4.66 % 4.58 % 4.74 % Insurance statutes regulate the types of investments that our insurance subsidiaries are permitted to make and limit the amount of funds that may be used for any one type of investment.
We expect to receive regulatory approval for future dividends from our subsidiaries, but there can be no assurance that such payments will be approved or that the financial condition of our insurance subsidiaries will not change, making future approvals less likely. CDOC holds surplus debentures from CLTX with an aggregate principal amount of $749.6 million.
We expect to receive regulatory approval for future dividends from our subsidiaries, but there can be no assurance that such payments will be approved or that the financial condition of our insurance subsidiaries will not change, making future approvals less likely.
The fee income segment is summarized below (dollars in millions): 2022 2021 2020 Fee revenue $ 169.3 $ 147.6 $ 106.0 Operating costs and expenses (145.6) (128.2) (89.3) Net fee income $ 23.7 $ 19.4 $ 16.7 The increase in fee revenue in 2022 is primarily due to the growth related to the sales of third party products in recent periods and changes to our revenue recognition assumptions reflecting favorable policy persistency.
The fee income segment is summarized below (dollars in millions): 2023 2022 2021 Fee revenue $ 177.6 $ 169.3 $ 147.6 Operating costs and expenses (146.6) (145.6) (128.2) Net fee income $ 31.0 $ 23.7 $ 19.4 Net fee income increased in 2023 and 2022 is primarily due to growth in the sales of third party products by our Consumer Division in recent periods and changes to our revenue recognition assumptions reflecting favorable policy persistency; partially offset by lower earnings related to services provided by Optavise.
At December 31, 2022, the subsidiaries of CLTX had earned surplus (deficit) as summarized below (dollars in millions): Subsidiaries of CLTX Earned surplus (deficit) Additional information Bankers Life $ 374.1 (a) Colonial Penn (454.6) (b) ____________________ (a) Bankers Life paid dividends of $65.0 million to CLTX in 2022.
At December 31, 2023, the subsidiaries of CLTX had earned surplus (deficit) as summarized below (dollars in millions): Subsidiaries of CLTX Earned surplus (deficit) Additional information Bankers Life $ 34.6 (a) Colonial Penn (499.5) (b) ____________________ (a) Bankers Life paid dividends of $459.3 million to CLTX in 2023.
Average net insurance liabilities (total insurance liabilities less: (i) amounts related to reinsured business; (ii) deferred acquisition costs; (iii) present value of future profits; and (iv) the value of unexpired options credited to insurance liabilities) were $8,480.5 million, $7,771.8 million and $7,123.4 million in 2022, 2021 and 2020, respectively, driven by deposits and reinvested returns in excess of withdrawals.
Average net insurance liabilities (policyholder account balances less: (i) amounts related to reinsured business; (ii) deferred acquisition costs; (iii) present value of future profits; and (iv) the value of unexpired options credited to insurance liabilities) were $9,337.3 million, $8,788.6 million and $7,915.7 million in 2023, 2022 and 2021, respectively, driven by deposits and reinvested returns in excess of withdrawals.
If the healthier policyholders allow their policies to lapse, this would reduce our premium income and profitability in the future. 70 Table of Contents Total premium collections were as follows (dollars in millions): 2022 2021 2020 Premiums collected by product: Annuities: Fixed indexed (first-year) $ 1,509.2 $ 1,347.8 $ 1,121.7 Fixed indexed (renewal) .3 .3 .4 Subtotal - fixed indexed annuities 1,509.5 1,348.1 1,122.1 Fixed interest (first-year) 83.7 40.4 33.5 Fixed interest (renewal) 3.7 5.0 3.8 Subtotal - fixed interest annuities 87.4 45.4 37.3 Other annuities (first-year) 7.7 6.9 5.6 Total annuities 1,604.6 1,400.4 1,165.0 Health: Supplemental health (first-year) 73.2 67.9 72.7 Supplemental health (renewal) 619.7 620.1 604.5 Subtotal – supplemental health 692.9 688.0 677.2 Medicare supplement (first-year) 34.2 40.3 54.2 Medicare supplement (renewal) 617.4 667.2 696.3 Subtotal - Medicare supplement 651.6 707.5 750.5 Long-term care (first-year) 20.8 20.7 18.3 Long-term care (renewal) 243.1 243.3 245.6 Subtotal - long-term care 263.9 264.0 263.9 Total health 1,608.4 1,659.5 1,691.6 Life insurance: Interest-sensitive (first-year) 42.1 41.5 44.3 Interest-sensitive (renewal) 185.8 177.9 162.2 Subtotal - interest-sensitive 227.9 219.4 206.5 Traditional (first-year) 151.0 163.9 136.9 Traditional (renewal) 532.9 512.5 496.2 Subtotal - traditional 683.9 676.4 633.1 Total life insurance 911.8 895.8 839.6 Collections on annuity, health and life products: Total first-year premium collections 1,921.9 1,729.4 1,487.2 Total renewal premium collections 2,202.9 2,226.3 2,209.0 Total collections on insurance products $ 4,124.8 $ 3,955.7 $ 3,696.2 Annuities include fixed indexed, fixed interest and other annuities sold to the senior market.
If the healthier policyholders allow their policies to lapse, this would reduce our premium income and profitability in the future. 69 Table of Contents Total premium collections were as follows (dollars in millions): 2023 2022 2021 Premiums collected by product: Annuities: Fixed indexed (first-year) $ 1,373.8 $ 1,509.2 $ 1,347.8 Fixed indexed (renewal) .1 .3 .3 Subtotal - fixed indexed annuities 1,373.9 1,509.5 1,348.1 Fixed interest (first-year) 197.0 83.7 40.4 Fixed interest (renewal) 2.7 3.7 5.0 Subtotal - fixed interest annuities 199.7 87.4 45.4 Other annuities (first-year) 9.6 7.7 6.9 Total annuities 1,583.2 1,604.6 1,400.4 Health: Supplemental health (first-year) 81.6 73.2 67.9 Supplemental health (renewal) 625.0 619.7 620.1 Subtotal – supplemental health 706.6 692.9 688.0 Medicare supplement (first-year) 39.0 34.2 40.3 Medicare supplement (renewal) 570.4 617.4 667.2 Subtotal - Medicare supplement 609.4 651.6 707.5 Long-term care (first-year) 19.4 20.8 20.7 Long-term care (renewal) 242.4 243.1 243.3 Subtotal - long-term care 261.8 263.9 264.0 Total health 1,577.8 1,608.4 1,659.5 Life insurance: Interest-sensitive (first-year) 40.8 42.1 41.5 Interest-sensitive (renewal) 196.2 185.8 177.9 Subtotal - interest-sensitive 237.0 227.9 219.4 Traditional (first-year) 145.8 151.0 163.9 Traditional (renewal) 554.2 532.9 512.5 Subtotal - traditional 700.0 683.9 676.4 Total life insurance 937.0 911.8 895.8 Collections on annuity, health and life products: Total first-year premium collections 1,907.0 1,921.9 1,729.4 Total renewal premium collections 2,191.0 2,202.9 2,226.3 Total collections on insurance products $ 4,098.0 $ 4,124.8 $ 3,955.7 Annuities include fixed indexed, fixed interest and other annuities sold to the senior market.
Expenses not allocated to product lines as adjusted for such significant items are summarized below (dollars in millions): 2022 2021 2020 Expenses not allocated to product lines $ 40.8 $ 80.5 $ 83.8 Experience refund related to a reinsurance agreement (a) 22.5 — — Net expenses related to significant legal and regulatory matters — (12.8) (23.5) Charge related to asset impairments — — (3.7) Transaction expenses related to acquisition of DirectPath — (2.5) — Adjusted total $ 63.3 $ 65.2 $ 56.6 _______________ (a) Under the terms of the reinsurance agreement to cede a substantial portion of our legacy long-term care block, we are entitled to receive an experience refund of up to $22.5 million if certain rate increases are approved and implemented.
Total allocated and unallocated expenses as adjusted for the significant items are summarized below (dollars in millions): 2023 2022 2021 Expenses allocated to product lines $ 599.0 $ 596.6 $ 566.5 Expenses not allocated to product lines 51.7 40.8 80.5 Experience refund related to a reinsurance agreement (a) — 22.5 — Net recoveries (expenses) related to significant legal and regulatory matters 21.7 — (12.8) Transaction expenses related to acquisition of Optavise — — (2.5) Adjusted total $ 672.4 $ 659.9 $ 631.7 _______________ (a) Under the terms of the reinsurance agreement to cede a substantial portion of our legacy long-term care block, we were entitled to receive an experience refund of up to $22.5 million if certain rate increases were approved and implemented.
The three-level hierarchy for fair value measurements is described in the note to the consolidated financial statements entitled "Fair Value Measurements." The following summarizes investments on our consolidated balance sheet carried at fair value by pricing source and fair value hierarchy level as of December 31, 2022 (dollars in millions): Quoted prices in active markets for identical assets (Level 1) Significant observable inputs (Level 2) Significant unobservable inputs (Level 3) Total fair value Priced by third-party pricing services $ 59.6 $ 21,310.3 $ — $ 21,369.9 Priced by independent broker quotations — 112.0 233.3 345.3 Priced by matrices — .8 — .8 Priced by other methods (a) — 13.1 120.1 133.2 Total $ 59.6 $ 21,436.2 $ 353.4 $ 21,849.2 Percent of total .3 % 98.1 % 1.6 % 100.0 % _______________ (a) Represents primarily securities benchmarked to comparable securities to determine fair value.
The three-level hierarchy for fair value measurements is described in the note to the consolidated financial statements entitled "Fair Value Measurements." The following summarizes investments on our consolidated balance sheet carried at fair value by pricing source and fair value hierarchy level as of December 31, 2023 (dollars in millions): Quoted prices in active markets for identical assets (Level 1) Significant observable inputs (Level 2) Significant unobservable inputs (Level 3) Total fair value Priced by third-party pricing services $ 24.2 $ 22,396.4 $ — $ 22,420.6 Priced by independent broker quotations — 113.0 185.0 298.0 Priced by matrices — .4 — .4 Priced by other methods (a) — 36.5 117.1 153.6 Total $ 24.2 $ 22,546.3 $ 302.1 $ 22,872.6 Percent of total .1 % 98.6 % 1.3 % 100.0 % _______________ (a) Represents primarily securities benchmarked to comparable securities to determine fair value.
There were no amounts outstanding under the Revolving Credit Agreement at December 31, 2022. 83 Table of Contents The scheduled principal and interest payments on our direct corporate obligations are as follows (dollars in millions): Principal Interest (a) 2023 $ — $ 60.8 2024 — 60.8 2025 500.0 (b) 47.8 2026 — (c) 34.3 2027 — 33.9 2028 and thereafter 650.0 (d) 293.2 $ 1,150.0 $ 530.8 _________________________ (a) Based on interest rates as of December 31, 2022.
The scheduled principal and interest payments on our direct corporate obligations are as follows (dollars in millions): Principal Interest (a) 2024 $ — $ 60.8 2025 500.0 (b) 47.7 2026 — (c) 34.3 2027 — 33.9 2028 — 34.0 2029 and thereafter 650.0 (d) 259.2 $ 1,150.0 $ 469.9 _________________________ (a) Based on interest rates as of December 31, 2023.
The Consumer Division serves individual consumers, engaging with them on the phone, virtually, online, face-to-face with agents, or through a combination of sales channels. This structure unifies consumer capabilities into a single division and integrates the strength of our agent sales forces with one of the largest direct-to-consumer insurance businesses with proven experience in advertising, web/digital and call center support.
This structure unifies consumer capabilities into a single division and integrates the strength of our agent sales forces with one of the largest direct-to-consumer insurance businesses with proven experience in advertising, web/digital and call center support.
In 2022, other non-operating items include a one-time restructuring charge of $7.1 million primarily related to an early retirement program. The program reduced our headcount by 2 percent and is expected to reduce run-rate expenses by approximately $10 million. Other non-operating items also include earnings attributable to VIEs that we are required to consolidate, net of affiliated amounts.
The program reduced our headcount by 2 percent and was expected to reduce run-rate expenses by approximately $10 million. Other non-operating items also include earnings attributable to VIEs that we are required to consolidate, net of affiliated amounts.
There are nine ratings above CNO's "BBB-" rating and twelve ratings that are below its rating. 84 Table of Contents Outlook We believe that the existing cash available to the holding company, the cash flows to be generated from operations and other transactions will be sufficient to allow us to meet our debt service obligations, pay corporate expenses and satisfy other financial obligations.
Outlook We believe that the existing cash available to the holding company, the cash flows to be generated from operations and other transactions will be sufficient to allow us to meet our debt service obligations, pay corporate expenses and satisfy other financial obligations.
We estimate that our fixed maturity securities and short-term investments (net of corresponding changes in insurance acquisition costs or loss recognition reserves) would decline in fair value by approximately $600 million if interest rates were to increase by 10 percent from their levels at December 31, 2022.
We estimate that our fixed maturity securities and short-term investments would decline in fair value by approximately $650 million if interest rates were to increase by 10 percent from their levels at December 31, 2023.